Authors:
SYLVESTER RJ
PARMAR MKB
KURTH K
OOSTERLINCK W
PAWINSKI A
VANDERMEIJDEN AP
Citation: Rj. Sylvester et al., CHOICE OF END-POINTS AND SAMPLE-SIZE FOR PROPHYLACTIC TRIALS IN TATL BLADDER-CANCER - RESULTS BASED ON A COMBINED ANALYSIS OF EORTC AND MRCRANDOMIZED TRIALS, The Journal of urology, 159(5), 1998, pp. 539-539
Authors:
COLLETTE L
SYLVESTER RJ
DENIS LJ
BOUFFIOUX C
KURTH K
VANDERMEIJDEN AP
PARMAR MKB
PAWINSKI A
Citation: L. Collette et al., THE 3-MONTH RECURRENCE AS A PROGNOSTIC FACTOR FOR THE LONG-TERM OUTCOME IN TATL BLADDER-CANCER - RESULTS OF A COMBINED ANALYSIS OF EORTC AND MRC RANDOMIZED TRIALS OF PROPHYLACTIC TREATMENT, The Journal of urology, 159(5), 1998, pp. 540-540
Authors:
BRAUSI M
KURTH K
VANDERMEIJDEN AP
SYLVESTER RJ
COLLETTE L
Citation: M. Brausi et al., VARIABILITY IN THE 3-MONTH RECURRENCE RATE AFTER TUR IN SUPERFICIAL TRANSITIONAL-CELL CARCINOMA (TCC) OF THE BLADDER - A COMBINED ANALYSIS OF 8 EORTC STUDIES, The Journal of urology, 159(5), 1998, pp. 541-541
Authors:
KURTH K
TUNN U
AY R
SCHRODER FH
PAVONEMACALUSO M
DEBRUYNE F
TENKATE F
DEPAUW M
SYLVESTER R
ESSED E
CAUBERGH RV
HOEKSTRA JW
DEVOOGT HJ
NEWLING DWW
DEREIJKE TM
MENSINK HJA
GROEN JM
JAKSE G
LEISINGER HJ
RICHARDS B
ADIB RA
ROBINSON M
DENIS L
BOUFFIOUX C
SCHULMAN C
CARPENTIER PJ
Citation: K. Kurth et al., ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - LONG-TERM RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN, ETHOGLUCID AND TRANSURETHRAL RESECTION ALONE, The Journal of urology, 158(2), 1997, pp. 378-384
Authors:
DEREIJKE TM
KURTH K
DEBOER EC
SCHAMHART DHJ
Citation: Tm. Dereijke et al., CURRENT INSIGHTS IN THE TREATMENT OF SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, Onkologie, 19(6), 1996, pp. 480-488